Plasminogen

Plasminogen is a protein made in your liver that circulates in the blood in an inactive form. When your body needs to dissolve a blood clot, plasminogen is converted to plasmin, an enzyme that breaks down fibrin, the main structural protein in clots. This process is called fibrinolysis and is essential for keeping blood vessels open after a clot has done its job.

A plasminogen test measures either how well the protein works (activity) or how much of it is present (antigen). Your clinician may order one or both types, often alongside other clotting and fibrinolysis tests, to understand your overall balance between forming and breaking down clots.

Too little plasminogen activity or amount can reduce your ability to clear clots and may lead to problems such as recurrent blockages or thick, wood-like lesions on mucous membranes in rare inherited conditions. Low results can also occur with certain medical conditions, like severe liver disease or widespread clotting, and with some treatments. Identifying a deficiency helps guide care, including management of complications and decisions about family testing in suspected inherited cases.

The test may be ordered if you have unusual eye or mucosal lesions, unexplained clots, poor wound or tissue healing, or if your care team is evaluating the fibrinolysis part of your clotting system. It can also be checked before or during therapies that affect fibrinolysis. Understanding your plasminogen status helps tailor treatment and monitor response when a disorder is present.

Results are interpreted in the context of your symptoms, medical history, medicines, and other lab tests. Activity tests show how well plasminogen functions, while antigen tests show how much is present. A reduced activity with a similarly reduced antigen level suggests a quantitative deficiency, while a reduced activity with a near-normal antigen level points toward a functional problem. When changes are acquired, both measurements may be affected by an underlying illness or treatment.

If your result is outside the expected range, your clinician may repeat the test, review any interfering factors, and order additional studies of fibrinolysis or genetic testing when an inherited condition is suspected. Management focuses on treating the underlying cause and preventing complications. Ask your clinician how these findings fit with your overall risk of clotting or bleeding and whether family members should be considered for evaluation.